BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1036 related articles for article (PubMed ID: 17507150)

  • 21. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
    Eden CG; Arora A; Rouse P
    BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic pelvic lymph node dissection following definitive radiotherapy for carcinoma of the prostate.
    Lund GO; Winfield HN; Donovan JF; See WA; Loening SA; Williams RD
    J Urol; 1997 Feb; 157(2):548-51. PubMed ID: 8996353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardized and simplified extended pelvic lymph node dissection during robot-assisted radical prostatectomy: the monoblock technique.
    Mattei A; Di Pierro GB; Grande P; Beutler J; Danuser H
    Urology; 2013 Feb; 81(2):446-50. PubMed ID: 23374827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Suardi N; Gallina A; Da Pozzo LF; Roscigno M; Zanni G; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
    Eur Urol; 2006 Nov; 50(5):1006-13. PubMed ID: 16959399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Laparoscopic pelvic lymph node dissection valuable in the staging of clinically localized prostate carcinoma].
    Froeling FM; Witjes JA; Oosterhof GO
    Ned Tijdschr Geneeskd; 1995 Mar; 139(12):618-22. PubMed ID: 7700405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
    Briganti A; Suardi N; Capogrosso P; Passoni N; Freschi M; di Trapani E; Gallina A; Capitanio U; Abdollah F; Tutolo M; Bianchi M; Salonia A; Da Pozzo LF; Montorsi F; Rigatti P
    Prostate; 2012 Feb; 72(2):186-92. PubMed ID: 21538428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node dissection during robotic-assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection.
    Katz DJ; Yee DS; Godoy G; Nogueira L; Chong KT; Coleman JA
    BJU Int; 2010 Aug; 106(3):391-6. PubMed ID: 20089113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.
    Mazzola C; Savage C; Ahallal Y; Reuter VE; Eastham JA; Scardino PT; Guillonneau B; Touijer KA
    BJU Int; 2012 May; 109(9):1323-8. PubMed ID: 21992661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
    Stone NN; Stock RG
    Mt Sinai J Med; 1999 Jan; 66(1):26-30. PubMed ID: 9989102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open pelvic lymph node dissection for prostate cancer: a reassessment.
    Campbell SC; Klein EA; Levin HS; Piedmonte MR
    Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Gallina A; Salonia A; Zanni G; Valiquette L; Graefen M; Huland H; Rigatti P; Montorsi F
    Eur Urol; 2007 Jun; 51(6):1573-81. PubMed ID: 17293026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic lymph node dissection after endoscopic submucosal dissection: a novel and minimally invasive approach to treating early-stage gastric cancer.
    Abe N; Mori T; Takeuchi H; Yoshida T; Ohki A; Ueki H; Yanagida O; Masaki T; Sugiyama M; Atomi Y
    Am J Surg; 2005 Sep; 190(3):496-503. PubMed ID: 16105543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional lymph node staging in prostate cancer: prognostic and therapeutic implications.
    Burkhard FC; Studer UE
    Surg Oncol; 2009 Sep; 18(3):213-8. PubMed ID: 19269808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes.
    Boris RS; Bhandari A; Krane LS; Eun D; Kaul S; Peabody JO
    BJU Int; 2009 Apr; 103(7):952-6. PubMed ID: 19076132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.